• Careers
Contact

Mansfield is a leading healthcare and life sciences strategy consulting firm as ranked by the Financial Times and Vault

We advise on corporate strategy, value creation and commercial due diligence by combining research, modelling and analysis with clinical, scientific and operational knowledge

Selected Clients and Assets we have worked on

Our Latest Insights

Expert analysis across healthcare, life sciences, pharma, social care and digital

Pet Food 2036: Growth and Disruption in Cat and Dog Food
Pet Food 2036: Growth and Disruption in Cat and Dog Food
Animal Health
Radiopharmaceuticals – where hot molecules meet cold capital
Radiopharmaceuticals – where hot molecules meet cold capital
Therapeutic Products and Innovation
GLP-1 2.0: Where the next wave of value will be created
GLP-1 2.0: Where the next wave of value will be created
Therapeutic Products and Innovation
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Health & Care
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Investment
Will primary care always be secondary for investors?
Will primary care always be secondary for investors?
Health & Care
Three key lessons for digital health investors from the demise of Babylon Health
Three key lessons for digital health investors from the demise of Babylon Health
Health & Care
A Quick Update on NHS Waiting Lists
A Quick Update on NHS Waiting Lists
Health & Care
The Evolving Roles of CDMOs
The Evolving Roles of CDMOs
Investment
Taking a closer look at French PE deals, the most active funds in the market, and what they invest in
Taking a closer look at French PE deals, the most active funds in the market, and what they invest in
Animal Health
View all

News & Insights

Healthcare news, data and analysis

Via Investors in Healthcare

Partners Group, one of the largest firms in the global private markets industry, has closed its eighth private equity secondaries programme with over US$9bn in total client commitments. The programme […]
Switzerland: Partners Group closes latest private equity secondaries programme with over US$9bn of total commitments
24 April 2026
Buy Out ,
News ,
Anthony Shontz ,
Partners Group ,
Switzerland
Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners acquired a majority stake in Tjoapack […]
Netherlands: Alcami to acquire contract packaging organisation Tjoapack
24 April 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – CRO/CMO/CDMO
Kurma Partners, a European healthcare venture capital firm and a Eurazeo group company, has announced the final closing of Biofund IV at €215m (US$252m), some 35% larger than its previous […]
France: Kurma Partners closes Biofund IV at €215m
23 April 2026
Healthcare ,
Life Sciences ,
News ,
Pharma ,
Venture
InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands our Life Sciences clinical research […]
Germany: Innodiab expands Certania’s Life Sciences capabilities in diabetes and obesity
23 April 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – CRO/CMO/CDMO
Bay Tree Private Equity, a UK-based private equity firm investing in lower mid-market businesses, has completed an investment in Medicare Insourcing Services, a provider of clinical insourcing services to the […]
UK: Bay Tree completes investment in Medicare Insourcing Services
23 April 2026
Debt ,
Diagnostics ,
Healthcare ,
M&A ,
News
Against a backdrop of geopolitical tension, valuation resets and shifting capital markets, life sciences dealmaking is not slowing, it is recalibrating. The tone at McDermott Will & Schulte’s Life Sciences […]
From uncertainty to opportunity: life sciences dealmaking resets – Insights from McDermott Will & Schulte’s Life Sciences Symposium
22 April 2026
Analysis ,
Life Sciences ,
News ,
Aymen Mahmoud ,
Emmanuelle Trombe
Praemia REIM, a key European real estate asset management player with an asset portfolio over half of which is in the healthcare/education sector, has appointed Lionel Paquin as Group CEO as part of […]
France: Praemia REIM appoints Lionel Paquin as CEO
22 April 2026
Care Homes ,
Education ,
Healthcare ,
News ,
People
Nasdaq-listed QuidelOrtho Corporation, a global leader of innovative in vitro diagnostics, has completed the acquisition of LEX Diagnostics for approximately US$100m. LEX Diagnostics is a UK-based molecular diagnostics company and a spin-out […]
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m
21 April 2026
Diagnostics ,
Healthcare ,
Life Sciences ,
M&A ,
Medtech – Hospital Equipment
Listed Advanced Medical Solutions (AMS) has confirmed it is in discussions with TA Associates, a US private equity firm investment team specialising in five target industries: technology, financial services, healthcare, […]
UK: AMS confirms discussions with TA Associates regarding a possible takeover
20 April 2026
Life Sciences ,
M&A ,
Medtech – Medical Devices and Implants ,
News ,
Public Equity
Germany-based real estate platform Carestone specialises in the development, construction and sale of senior living and care home assets. Headquartered in Hanover, it has become one of the leading developers […]
Financing the future of elderly care in Germany: Carestone CEO Daniel Ahrendt talks market dynamics and growth
20 April 2026
Analysis ,
Care Homes ,
News ,
Real Assets ,
Social Care
Northern Horizon, a specialised social infrastructure asset manager in the Nordics, has completed three forward funding deals acquisitions in Finland for approximately €28m. The new assets – in Jyväskylä, Pori and Kuopio […]
Finland: Northern Horizon expands in Finland through three forward-funding deals
20 April 2026
Care Homes ,
News ,
Real Assets ,
Social Care ,
Finland
Affidea, a Netherlands-based leading pan-European provider of community-based polyclinics, specialised services and advanced diagnostics, has transferred its operations in Hungary to local healthcare provider Medicare Group. Formed in Hungary in 1998, […]
Hungary: Affidea exits Hungary with operations transferring to Medicare Group
20 April 2026
Diagnostics ,
Healthcare ,
M&A ,
News ,
Affidea
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, has €40.6m by way of an accelerated bookbuild offering through […]
Netherlands: EQT Life Sciences takes €25m of Onward’s €40m private placement
17 April 2026
Life Sciences ,
Medtech – Hospital Equipment ,
Medtech – Medical Devices and Implants ,
News ,
Public Equity
Sweden-based international medical imaging IT and cybersecurity company Sectra has completed the acquisition of Lithuania-based Oxipit, a pioneer in autonomous AI for radiology and the developer of the first solution with […]
Lithuania: Sectra strengthens position as provider of advanced, regulatory-approved AI solutions for diagnostic imaging with acquisition of Oxipit
17 April 2026
Diagnostics ,
Healthcare ,
Life Sciences ,
M&A ,
Medtech – Diagnostics
Singapore-based private equity firm Everstone Capital has partnered with the founding promoters of India-based Apothecon and US-based Navinta, investing close to US$270m for a substantial stake in the Apothecon Group. […]
India: Everstone Capital invests close to US$270m for a substantial stake in the Apothecon Group
17 April 2026
Manufacturing – Generics ,
News ,
Pharma ,
Venture ,
Apothecon
Charterhouse Capital Partners has reached an agreement to acquire all shares of York-based AIM-listed international veterinary sales and marketing organisation, Animalcare, for approximately £235.2m on a fully diluted basis. Under the […]
UK: Charterhouse reaches agreement on recommended acquisition of Animalcare
16 April 2026
Animal Health ,
M&A ,
News ,
Public Equity ,
Veterinary
The British Business Bank, the UK government’s economic development bank, has agreed to make a £100m (US$135.5m) commitment to Apposite Healthcare Growth I, a fund investing to support the growth […]
UK: British Business Bank agrees £100m cornerstone commitment to Apposite Healthcare Growth I
16 April 2026
Diagnostics ,
Digital Health/Healthtech ,
Healthcare ,
Life Sciences ,
News
Cofinimmo, the Belgium-based REIT merging with Aedifica, is build a new nursing and care home in Seville, Spain. The investment budget for both the plot of land and the works […]
Spain: Cofinimmo to build 150-bed care home in Spain
16 April 2026
Care Homes ,
News ,
Real Assets ,
Social Care ,
Cofinimmo
Knight Frank Australia is expanding its Healthcare and Life Sciences team with the appointment of Clem Stack. Stack brings more than five years’ commercial property experience at Knight Frank, having […]
Australia: Knight Frank expands its Healthcare and Life Sciences team in Australia with appointment of Clem Stack
15 April 2026
Care Homes ,
Complex Behavioural Care ,
Healthcare ,
Life Sciences ,
News
Cera, Europe’s largest HealthTech, is making an eight-figure investment to build the world’s first AI Lab for care sector, backed by UK Government. The initiative aims to address the global […]
UK: Cera commits to eight-figure investment in AI Lab to help solve care capacity gap
15 April 2026
Digital Health/Healthtech ,
Healthcare ,
Homecare ,
News ,
Social Care
Hong Kong-listed Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialisation of innovative therapeutics, has announced that its wholly-owned subsidiary, EverSea Medicines (Singapore), has entered […]
Singapore: Everest Medicines to acquire Hasten Biopharmaceuticals (SG) for US$250m
15 April 2026
Distribution ,
Healthcare ,
M&A ,
News ,
Everest Medicines
Adcendo, a Denmark-based biotech company focused on the development of first-and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical need, has closed an oversubscribed US$75m […]
Denmark: Adcendo completes US$75m Series C financing round
14 April 2026
News ,
Pharma ,
Venture ,
Adcendo ,
BPI France
Space is rapidly evolving from a theatre of exploration into a platform for high‑value industries, such as pharmaceuticals. As in‑orbit manufacturing becomes more technically and commercially viable, it is opening […]
The new space race: zero gravity drug development
14 April 2026
Analysis ,
Legal ,
News ,
Pharma ,
Carpmaels & Ransford
Ceva Animal Health, the world’s fifth largest animal health company, has appointed Sébastien Huron as deputy CEO. The appointment forms part of a broader governance change in which the firm […]
France: Ceva Animal Health appoints Sébastien Huron as deputy CEO as part of broader governance change
14 April 2026
News ,
People ,
Veterinary ,
Ceva Santé Animale ,
France
Nord Holding is investing in the VisionmaxX Group, the leading managed service provider (MSP) for IT services in German Austrian medical practices with a focus on the dental sector. Nord […]
Germany: Nord Holding acquiring stake in VisionmaxX Group
13 April 2026
Dental ,
Healthcare ,
Life Sciences ,
Medtech – Healthcare IT ,
News